SCHEMBL19974429

SCHEMBL19974429

O=C(O)C=CC(=O)Nc1ccnc(-c2cccnc2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.64
KDM4E B2RXH2 4/20 0.64
LPAR2 Q9HBW0 2/20 0.52
LPAR1 Q92633 1/20 0.52
MAPT P10636 3/20 0.51
KMT2A Q03164 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
FTO Q9C0B1 1/20 0.50
PPARG P37231 1/20 0.50
CREBBP Q92793 1/20 0.49
PARP1 P09874 2/20 0.48
PARP15 Q460N3 2/20 0.48
PARP14 Q460N5 2/20 0.48
PARP10 Q53GL7 2/20 0.48
LPAR3 Q9UBY5 2/20 0.48
PRKD3 O94806 1/20 0.47
ABL1 P00519 1/20 0.47
PRKCG P05129 1/20 0.47
PRKCB P05771 1/20 0.47
PDGFRB P09619 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23647316 1.00 ALDH1A1 (0.64) ALDH1A1KDM4ELPAR2LPAR1MAPT
SCHEMBL19974422 0.89 ALDH1A1 (0.59) ALDH1A1KDM4ELPAR2LPAR1MAPT
SCHEMBL23647318 0.89 ALDH1A1 (0.59) ALDH1A1KDM4ELPAR2LPAR1MAPT
SCHEMBL19974536 0.85 ALDH1A1 (0.55) ALDH1A1KDM4ELPAR2LPAR1MAPT
SCHEMBL19974537 0.85 ALDH1A1 (0.55) ALDH1A1KDM4ELPAR2LPAR1MAPT
SCHEMBL30271564 0.83 LMNA (0.52) ALDH1A1KDM4EMAPTKMT2APPARG
SCHEMBL23657122 0.83 LMNA (0.52) ALDH1A1KDM4EMAPTKMT2APPARG
SCHEMBL19974204 0.81 NMT1 (0.60) ALDH1A1KDM4ELPAR2LPAR1MAPT
SCHEMBL19974201 0.81 NMT1 (0.60) ALDH1A1KDM4ELPAR2LPAR1MAPT
SCHEMBL17667093 0.79 ALDH1A1 (1.00) ALDH1A1KDM4ELPAR2LPAR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512602-B1 INHIBITORS OF HEAT SHOCK FACTORS (HSF) AND USES THEREOF HSF PHARMACEUTICALS (CH) 2024-03-27 EP disclosed
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2023-03-07 US disclosed
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2021-07-22 US disclosed
EP-3512602-A2 INHIBITORS OF HEAT SHOCK FACTORS AND USES THEREOF HSF Pharmaceuticals (CH) 2019-07-24 EP disclosed
WO-2018050656-A2 INHIBITORS OF HEAT SHOCK FACTORS AND USES THEREOF HSF PHARMACEUTICALS (CH) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 ALDH1A1 2641/4885KDM4E 2977/4885LPAR2 4462/4885
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 ALDH1A1 2641/4885KDM4E 2977/4885LPAR2 4462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.